Heavy cannabis use prior psychosis in schizophrenia: clinical, cognitive and neurological evidences for a new endophenotype?

被引:0
作者
Jasmina Mallet
Nicolas Ramoz
Yann Le Strat
Philip Gorwood
Caroline Dubertret
机构
[1] University Hospital Louis-Mourier,Department of Psychiatry
[2] Assistance Publique-Hôpitaux de Paris (AP-HP),Faculty of Medicine
[3] University Paris 7 Denis Diderot,INSERM U894
[4] Center of Psychiatry and Neuroscience,CMME
[5] University Paris 5 René Descartes,undefined
[6] PRES Sorbonne Paris cité,undefined
[7] Sainte-Anne Hospital,undefined
来源
European Archives of Psychiatry and Clinical Neuroscience | 2017年 / 267卷
关键词
Schizophrenia; Neurological soft signs; Cannabis; Cognition; Neurodevelopment;
D O I
暂无
中图分类号
学科分类号
摘要
Cannabis use is associated with an increased risk of schizophrenia, and is considered to impact late neurodevelopment. Neurological soft signs (NSS) associated with schizophrenia are considered as markers of early neurodevelopmental impairment. Our study examines the association between heavy cannabis use before the onset of psychosis and clinical, neuropsychological and neurological symptoms, including NSS. In a cross-sectional study, we consecutively included 61 patients with schizophrenia (34 reporting heavy cannabis use before the onset of psychosis and 27 not reporting such use), in the setting of a University Hospital and a Medical Center. Symptoms assessment and substance use disorder were evaluated with the Diagnostic Interview for Genetic Studies. NSS were assessed with the Neurological Evaluation Scale. Psychopathology was assessed with the Positive and Negative Symptom Scale. All patients underwent a battery of neurocognitive tests evaluating attention, memory and executive functions domains. Patients with heavy cannabis use before the onset of psychosis showed significantly less NSS (p < 0.05), less negative symptoms (p < 10−3) and a better cognitive functioning in different domains [median reaction time (p = 0.03), episodic memory (p = 0.04), visuoconstructive praxs (p = 0.03) than their non-heavy user counterparts]. Confounding effects of alcohol and tobacco were taken into account. Age and gender were not statistically different between the two groups (p = 0.70 and p = 0.16, respectively). Our study supports the clinical, neuropsychological and neurological specificity associated with the heavy use of cannabis before the onset of schizophrenia. Patients with heavy cannabis use before the onset of schizophrenia may exhibit later neurodevelopmental impairment than those who do not report such use. Schizophrenia associated with heavy cannabis use could represent a specific phenotype.
引用
收藏
页码:629 / 638
页数:9
相关论文
共 160 条
[31]  
Di Forti M(2002)Cannabis and neurological soft signs in schizophrenia: absence of relationship and influence on psychopathology Psychopathology 35 289-295
[32]  
Lewis CM(2003)Drug abuse and/or dependence and better neuropsychological performance in patients with schizophrenia Schizophr Res 63 297-299
[33]  
Moore THM(1998)Calgary Depression Scale for Schizophrenia: a study of the validity of a French-language version in a population of schizophrenic patients Acta Psychiatr Scand 97 36-41
[34]  
Zammit S(2002)The National Adult Reading Test as a measure of premorbid intelligence: a comparison with estimates derived from demographic variables J Int Neuropsychol Soc JINS 8 847-854
[35]  
Lingford-Hughes A(1994)Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative Arch Gen Psychiatry 51 849-859
[36]  
Dekker N(1987)The positive and negative syndrome scale (PANSS) for schizophrenia Schizophr Bull 13 261-276
[37]  
Schmitz N(1989)The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia Psychiatry Res 27 335-350
[38]  
Peters BD(1984)A demographically based index of premorbid intelligence for the WAIS—R J Consult Clin Psychol 52 885-887
[39]  
Epstein KA(1995)Reliability of the Rey-Osterrieth Complex Figure in use with memory-impaired patients J Clin Exp Neuropsychol 17 566-579
[40]  
Kumra S(2002)Testing the efficiency and independence of attentional networks J Cogn Neurosci 14 340-347